SAVVY Vaginal Gel
Alternative Name: C31G Vaginal Gel
Description: C31G Vaginal Gel (1%) has components myristamine oxide and cetyle betaine.
Product Details
User: Female
Hormonal: No
Delivery Method: Vaginal Gel
Duration Type: Short-acting
Active Pharmaceutical Ingredient (API): - myristamine oxide
- cetyl betaine
- myristamine oxide
- cetyl betaine
Multipurpose Preventive Technology (MPT): Yes
Status Details
Developer: Adamis Pharmaceuticals
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Phase III
Active Development: No
Additional Information
References: ClinicalTrials.gov Identified NCT00274261
ClinicalTrials.gov Identified NCT00274261